The prognostic and therapeutic potential of vimentin in colorectal cancer
- PMID: 39347868
- DOI: 10.1007/s11033-024-09965-w
The prognostic and therapeutic potential of vimentin in colorectal cancer
Abstract
Several cells and molecules in the tumor microenvironment have been introduced as effective factors in the prognosis and progression of colorectal cancer. As a key element of the intermediate filament family, vimentin is expressed by mesenchymal cells in a ubiquitous manner and contributes significantly to cellular integrity and stress resistance in colorectal cancer. Recent studies have shown that alterations in the expression patterns of intermediate filaments are significantly related to cancer progression, especially in phenotypes associated with cellular migration and invasion. In addition to its multiple biological roles, vimentin also has a substantial function in mediating the epithelial-mesenchymal transition. Therefore, evaluating vimentin as an effective factor involved in the prognosis of colorectal cancer and targeting it as a novel approach to cancer therapy have become one of the main goals of many researchers worldwide. In this article, we will review the various biological functions of vimentin, as well as its relationship with colorectal cancer with the aim of providing novel insights into its clinical importance in the prognosis and treatment of colorectal cancer.
Keywords: Colorectal cancer; Prognostic marker; Therapeutic target; Vimentin.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.Carcinogenesis. 2013 Nov;34(11):2548-57. doi: 10.1093/carcin/bgt282. Epub 2013 Sep 3. Carcinogenesis. 2013. PMID: 24001454
-
Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer.Cancer Biomark. 2017 Jul 19;20(1):107-122. doi: 10.3233/CBM-170034. Cancer Biomark. 2017. PMID: 28759954
-
ID4 predicts poor prognosis and promotes BDNF-mediated oncogenesis of colorectal cancer.Carcinogenesis. 2021 Jul 16;42(7):951-960. doi: 10.1093/carcin/bgab037. Carcinogenesis. 2021. PMID: 33993270
-
Regulatory mechanisms and clinical significance of vimentin in breast cancer.Biomed Pharmacother. 2021 Jan;133:111068. doi: 10.1016/j.biopha.2020.111068. Epub 2020 Dec 8. Biomed Pharmacother. 2021. PMID: 33378968 Review.
-
Vimentin in cancer and its potential as a molecular target for cancer therapy.Cell Mol Life Sci. 2011 Sep;68(18):3033-46. doi: 10.1007/s00018-011-0735-1. Epub 2011 Jun 3. Cell Mol Life Sci. 2011. PMID: 21637948 Free PMC article. Review.
References
-
- Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74(1):12–49
-
- Bray F et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
-
- Naxerova K et al (2017) Origins of lymphatic and distant metastases in human colorectal cancer. Science 357(6346):55–60
-
- Bajpai P et al (2024) Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer. J Exp Clin Cancer Res 43(1):192
-
- Lin YM et al (2021) Image-guided ablation for colorectal liver metastasis: principles, current evidence, and the path Forward. Cancers (Basel), 13(16)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous